Chronic Fatigue Syndrome (ME/CFS) is a common and severe disease with a considerable social and economic impact. So far the etiology is not known, and neither a diagnostic marker nor a licensed treatment is are available yet. The EUROMENE network of European researchers and clinicians aims to promote cooperation and advance research on ME/CFS. To improve diagnosis and facilitate clinical trials diagnostic markers are urgently needed. As a first step for developing biomarkers for clinical use a database of active biomarker research in Europe was established called the ME/CFS EUROMENE Biomarker Landscape project and results are presented in this review. Further we suggest strategies to improve biomarker development and encourage researchers to take these into consideration for designing and reporting biomarker studies.
The European ME/CFS Biomarker Landscape project - an initiative of the European network EUROMENE
CAPELLI, ENRICA;
2017-01-01
Abstract
Chronic Fatigue Syndrome (ME/CFS) is a common and severe disease with a considerable social and economic impact. So far the etiology is not known, and neither a diagnostic marker nor a licensed treatment is are available yet. The EUROMENE network of European researchers and clinicians aims to promote cooperation and advance research on ME/CFS. To improve diagnosis and facilitate clinical trials diagnostic markers are urgently needed. As a first step for developing biomarkers for clinical use a database of active biomarker research in Europe was established called the ME/CFS EUROMENE Biomarker Landscape project and results are presented in this review. Further we suggest strategies to improve biomarker development and encourage researchers to take these into consideration for designing and reporting biomarker studies.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
